{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:14:32Z","timestamp":1791231272500,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2016GXNSFAA380175"],"award-info":[{"award-number":["2016GXNSFAA380175"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00296-018-4071-8","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T09:58:40Z","timestamp":1527674320000},"page":"1511-1519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-9090","authenticated-orcid":false,"given":"Jie","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-7740","authenticated-orcid":false,"given":"Ling","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-1199","authenticated-orcid":false,"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-1493","authenticated-orcid":false,"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2823-3020","authenticated-orcid":false,"given":"Jing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"20","key":"4071_CR1","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.3760\/cma.j.issn.0366-6999.20141395","volume":"127","author":"N Jiang","year":"2014","unstructured":"Jiang N, Li M, Zeng X (2014) Correlation of Th17 cells and CD4+ CD25+ regulatory T cells with clinical parameters in patients with systemic sclerosis. Chin Med J 127(20):3557\u20133561","journal-title":"Chin Med J"},{"issue":"4","key":"4071_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37(4):223\u2013235","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"4071_CR3","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s10067-015-3006-y","volume":"34","author":"AT Dantas","year":"2015","unstructured":"Dantas AT, Goncalves SM, Pereira MC, Goncalves RS, Marques CD, Rego MJ, Pitta IR, Duarte AL, Pitta MG (2015) Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement. Clin Rheumatol 34(9):1621\u20131625","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4071_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","volume":"40","author":"SY Guan","year":"2017","unstructured":"Guan SY, Leng RX, Khan MI, Qureshi H, Li XP, Ye DQ, Pan HF (2017) Interleukin-35: a potential therapeutic agent for autoimmune diseases. Inflammation 40(1):303\u2013310","journal-title":"Inflammation"},{"issue":"12","key":"4071_CR5","first-page":"2273","volume":"54","author":"M Tomcik","year":"2015","unstructured":"Tomcik M, Zerr P, Palumbo-Zerr K, Storkanova H, Hulejova H, Spiritovic M, Kodet O et al (2015) Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease. Rheumatology 54(12):2273\u20132282","journal-title":"Rheumatology"},{"issue":"1","key":"4071_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1\u201311","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"4071_CR7","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/art.11129","volume":"48","author":"C Chizzolini","year":"2003","unstructured":"Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM (2003) Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Arthritis Rheum 48(9):2593\u20132604","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4071_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-017-01571-8","volume":"8","author":"D Hu","year":"2017","unstructured":"Hu D, Notarbartolo S, Croonenborghs T, Patel B, Cialic R et al (2017) Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun 8(1):1600","journal-title":"Nat Commun"},{"issue":"3","key":"4071_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","volume":"139","author":"D Fenoglio","year":"2011","unstructured":"Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G et al (2011) Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol 139(3):249\u2013257","journal-title":"Clin Immunol"},{"issue":"12","key":"4071_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093\u20131101","journal-title":"Nat Immunol"},{"issue":"11","key":"4071_CR11","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"issue":"Suppl 5","key":"4071_CR12","doi-asserted-by":"publisher","first-page":"v45","DOI":"10.1093\/rheumatology\/kex199","volume":"56","author":"M Cutolo","year":"2017","unstructured":"Cutolo M, Smith V, Furst DE, Khanna D, Herrick AL (2017) Points to consider-Raynaud\u2019s phenomenon in systemic sclerosis. Rheumatology 56(Suppl 5):v45\u2013v48","journal-title":"Rheumatology"},{"issue":"1","key":"4071_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2(1):11\u201318","journal-title":"J Scleroderma Relat Disord"},{"issue":"Suppl 5","key":"4071_CR14","doi-asserted-by":"publisher","first-page":"v53","DOI":"10.1093\/rheumatology\/kex202","volume":"56","author":"G Kum\u00e1novics","year":"2017","unstructured":"Kum\u00e1novics G\u200b, P\u00e9ntek M, Bae S, Opris D, Khanna D, Furst DE, Czirj\u00e1k L (2017) Assessment of skin involvement in systemic sclerosis. Rheumatology 56(Suppl 5):v53\u2013v66 \u00a0","journal-title":"Rheumatology"},{"issue":"2","key":"4071_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE et al (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134(2):358\u2013367","journal-title":"Chest"},{"issue":"10103","key":"4071_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699","journal-title":"Lancet"},{"issue":"9","key":"4071_CR17","first-page":"1809","volume":"35","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Colaci M, Giuggioli D, Ferrari SM, Frascerra S, Franzoni F, Galetta F, Ferrannini E (2008) Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. J Rheumatol 35(9):1809\u20131811","journal-title":"J Rheumatol"},{"issue":"3","key":"4071_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1046\/j.1365-2249.2002.02017.x","volume":"130","author":"H Fujii","year":"2002","unstructured":"Fujii H, Hasegawa M, Takehara K, Mukaida N, Sato S (2002) Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis. Clin Exp Immunol 130(3):548\u2013556","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"4071_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.patbio.2009.11.003","volume":"60","author":"J Baraut","year":"2012","unstructured":"Baraut J, Farge D, Jean-Louis F, Kesmandt H, Durant C, Verrecchia F, Michel L (2012) Cytokines in systemic sclerosis. Pathol Biol (Paris) 60(2):127\u2013139","journal-title":"Pathol Biol (Paris)"},{"key":"4071_CR20","doi-asserted-by":"publisher","first-page":"390563","DOI":"10.1155\/2013\/390563","volume":"2013","author":"P Cordiali-Fei","year":"2013","unstructured":"Cordiali-Fei P, Mussi A, D'Agosto G, Trento E, Bordignon V, Trincone S, Vento A, Sperduti I, Cristaudo A, Ensoli F (2013) Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease. Clin Dev Immunol 2013:390563","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"4071_CR21","first-page":"14","volume":"100","author":"L Lei","year":"2016","unstructured":"Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN (2016) Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol 100(5):14\u201322","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"4071_CR22","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00296-011-2056-y","volume":"32","author":"TS Rodriguez-Reyna","year":"2012","unstructured":"Rodriguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Martinez-Reyes C, D\u00edaz-Zamudio M, Llorente L (2012) Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatol Int 32(9):2653\u20132660","journal-title":"Rheumatol Int"},{"issue":"11","key":"4071_CR23","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","volume":"43","author":"K Kurasawa","year":"2000","unstructured":"Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43(11):2455\u20132463","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4071_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-3083.2011.02567.x","volume":"74","author":"GN Andersen","year":"2011","unstructured":"Andersen GN, Nilsson K, Nagaeva O, Rantap\u00e4\u00e4-Dahlqvist S, Sandstr\u00f6m T, Mincheva-Nilsson L (2011) Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response. Scand J Immunol 74(3):272\u2013281","journal-title":"Scand J Immunol"},{"issue":"7169","key":"4071_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DA (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566\u2013569","journal-title":"Nature"},{"issue":"11","key":"4071_CR26","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","volume":"37","author":"W Niedbala","year":"2007","unstructured":"Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021\u20133029","journal-title":"Eur J Immunol"},{"issue":"8","key":"4071_CR27","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.4049\/jimmunol.1402362","volume":"195","author":"H Kudo","year":"2015","unstructured":"Kudo H, Wang Z, Jinnin M, Nakayama W, Inoue K, Honda N, Nakashima T et al (2015) EBI3 downregulation contributes to type I collagen overexpression in scleroderma skin. J Immunol 195(8):3565\u20133573","journal-title":"J Immunol"},{"issue":"4","key":"4071_CR28","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","volume":"135","author":"KG MacDonald","year":"2015","unstructured":"MacDonald KG, Dawson NA, Huang Q, Dunne JV, Levings MK, Broady R (2015) Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis. J Allergy Clin Immunol 135(4):946\u2013949","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4071_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs142","volume":"95","author":"P Kanellakis","year":"2012","unstructured":"Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A (2012) A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res 95(1):77\u201385","journal-title":"Cardiovasc Res"},{"issue":"10","key":"4071_CR30","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/art.22927","volume":"56","author":"Y Parel","year":"2007","unstructured":"Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C (2007) Presence of CD4+ CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 56(10):3459\u20133467","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4071_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12026-017-8926-y","volume":"65","author":"M Furue","year":"2017","unstructured":"Furue M, Mitoma C, Mitoma H, Tsuji G, Chiba T, Nakahara T, Uchi H, Kadono T (2017) Pathogenesis of systemic sclerosis\u2014current concept and emerging treatments. Immunol Res 65(4):790\u2013797","journal-title":"Immunol Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4071-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T04:46:25Z","timestamp":1720327585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4071-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Ethical Committee of the First Affiliated Hospital of GuangXi Medical University. Written informed consent was obtained from all patients and healthy controls.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have no conflict of interest to declare. There is no any interest or relationship with pharmaceutical agencies within the past 36\u00a0months.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}